跳至主要内容
临床试验/CTRI/2024/07/070075
CTRI/2024/07/070075尚未招募2/3 期

A Randomized Controlled Trial to Evaluate the Effect of Lifestyle Modifications in Asrigdara

National Institute of Ayurveda Jaipur1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2024年7月18日最近更新:

试验速览

阶段
2/3 期
状态
尚未招募
发起方
入组人数
60
试验地点
1
主要终点
changes in assessment criteria

研究概览

简要总结

Need of Study:Asrigdara is very much common in clinical practices. In modern it is related with AUB having prevalence is estimated to be 30% .In India, the reported prevalence of Asrigdara(AUB) is around 17.9%.

Females are very much suffered due to this disease physically and psychologically. Other contemporary system medicines not provided sufficient patient friendly  ways to reduce or cure this problem.

 Conditions cannot be  corrected until the lifestyle is not modified which is the root cause in most of the cases . Lifestyle modifications are easy to follow, easily acceptable and cost effective  as  well as goes with daily routine easily.

 Not any such type of work has been done till now, so it can provide another treatment option for this disease.

 Lifestyle modifications  correct the hormonal secretions at various levels and improve the metabolism which is very much needed in this disease.

 Aim and Objectives:

Aim: Clinical Evaluation of Lifestyle Modifications in Asrigdara

Objectives: Evaluation of the effect of Lifestyle Modifications in the terms of Dinacharya, Aahar and Yoga in Asrigdara through a Randomized Controlled Trial

Research Question: Are Lifestyle Modifications effective in Asrigdara?

Null Hypothesis: There is no effect of Lifestyle Modifications in Asrigdara.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
None

入排标准

年龄范围
12.00 Year(s) 至 50.00 Year(s)(—)
性别
Female

入选标准

  • Women between age group 12 to 50 years both married and Unmarried Patients having any one or two of the following features will be included Heavy menstrual bleeding Prolonged menstrual bleeding Intermenstrual bleeding Hb percent equal to or more than 8gm dl Patients with excessive bleeding for at least two consecutive cycles.

排除标准

  • Patients with bleeding diathesis Pregnancy Patients using drugs that may cause vaginal bleeding patients with any organic pathology to explain the bleeding in gynecological examination Patients using IUCD and OCP Bleeding followed by abortion Any systemic disease History of reproductive system disorder like organic pelvic pathology benign and malignant tumours PID congenital anomalies of genital tract and different types of infections.

结局指标

主要结局

changes in assessment criteria

时间窗: at base line 30 days 60 days

Assessment Criteria

时间窗: at base line 30 days 60 days

Asirgdar is assessed by on the basis of following criteria:

时间窗: at base line 30 days 60 days

Atyadhik matra Heavy amount of menstrual blood

时间窗: at base line 30 days 60 days

Atyadhik kaal Menstrual phase is more than normal

时间窗: at base line 30 days 60 days

Anritukala pravritti Menstrual blood flow other than cycle or between cycle

时间窗: at base line 30 days 60 days

次要结局

未报告次要终点

研究者

发起方
National Institute of Ayurveda Jaipur
申办方类型
Government medical college
责任方
Principal Investigator
主要研究者

Dr Durgawati Devi

National Institute of Ayurveda Jaipur Rajasthan

研究点 (1)

Loading locations...

相似试验

Evaluate the effect of Lifestyle Modifications in... | 临床试验